Cold snare biopsies in the ileum and colon for translational studies in inflammatory bowel disease: a feasibility study
- Conditions
- Inflammatory Bowel Disease10017969
- Registration Number
- NL-OMON56844
- Lead Sponsor
- Amsterdam UMC
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- Not specified
- Target Recruitment
- 34
Inflammatory Bowel Disease (IBD) (Crohn*s disease (CD) or ulcerative colitis
(UC)) patients who are planned to undergo a routine IBD colonoscopy with the
collection of biopsies for disease activity assessment; >=18 years old; active
disease (defined as Mayo>1 for UC or SES-CD>2 for CD); ability to provide
informed consent.
Complete remission; history of colonic perforation during endoscopic
procedures; active use of anticoagulant medications; familial history of
bleeding disorders; known individual bleeding disorders; suspicion of dysplasia
or colorectal carcinoma.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method <p>Sample quality will be assessed based on the measure of cell yield, which<br /><br>quantifies the number of cells obtained in the biopsy samples. A higher cell<br /><br>yield typically indicates better sample quality, making it a key metric for<br /><br>evaluating the effectiveness of the biopsy procedures. In addition, the<br /><br>different cell types present in the biopsies will be analysed.</p><br>
- Secondary Outcome Measures
Name Time Method <p>Significant intra-procedural bleeding: as objectified by the endoscopist<br /><br>Post-procedural bleeding: defined as rectal blood-loss that requires<br /><br>re-colonoscopy: persistent bleeding (>2 days after procedure)<br /><br>Perforation (objectified on cross-sectional imaging)<br /><br>Infection: defined as formation of an abscess, appendicitis or peritonitis<br /><br>Other adverse events related to the biopsy procedure (abdominal pain, cramps)<br /><br>Patient discomfort</p><br>